TrialLeukemia2016

Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients.

H Hjorth-Hansen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.